EUVIMEDEUVIMED entdecken
Editorial

NRF2: New Mechanistic Insights and Therapeutic Perspectives

Jerzy W Kupiec-Weglinski iD

Antioxidants & Redox Signaling · 2024-04 · 40 (10-12) · 632-635

DOI: 10.1089/ars.2023.0398 ↗

Kurz gefasst

Editorial in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 03.04.2024. Verfasst von Jerzy W Kupiec-Weglinski. Beteiligte Einrichtung: The Dumont-UCLA Transplantation Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCL…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Oxidative Stress. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted modulation of a dynamic interplay between transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) and its negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), is of paramount importance in maintaining redox, metabolic, and protein homeostasis and regulating inflammation responses. Indeed, inducible NRF2 activation promotes cytoprotective mechanisms against many immune, neurodegenerative, and metabolic disorders with oxidative stress and inflammation as underlying pathological features. In this ARS Forum, five state-of-the-art reviews and two original research communications report on canonical and newly discovered molecular mechanisms by which the NRF2–KEAP1 axis controls fundamental cell life or death decisions and exerts biological functions under environmental and endogenous stress conditions. Although the use of NRF2 activators represents a promising pharmacological strategy to regain and maintain homeostasis, challenges regarding their double-edged character, target specificity, pharmacodynamic properties, efficacy, and safety must be critically considered. More translational studies are warranted before NRF2 agonists (inducers or enhancers) become an integral part of our therapeutic armamentarium. Antioxid. Redox Signal . 40, 632–635.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Oxidative StressHumansKelch-Like ECH-Associated Protein 1InflammationOxidation-Reduction

Stichwörter der Autor:innen

HO-1KEAP1NRF2

Substanzen

NF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1

Autor:innen und Institutionen

  • The Dumont-UCLA Transplantation Center, Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

ORCID-Profile: Jerzy W Kupiec-Weglinski

Zitieren

APA

Kupiec-Weglinski, J. W. (2024). NRF2: New Mechanistic Insights and Therapeutic Perspectives. Antioxidants & Redox Signaling, 40(10-12), 632-635. https://doi.org/10.1089/ars.2023.0398

Vancouver

Kupiec-Weglinski JW. NRF2: New Mechanistic Insights and Therapeutic Perspectives. Antioxidants & Redox Signaling. 2024;40(10-12):632-635. doi:10.1089/ars.2023.0398

BibTeX
@article{KupiecWeglinski2024,
  author = {Kupiec-Weglinski, Jerzy W},
  title = {NRF2: New Mechanistic Insights and Therapeutic Perspectives},
  journal = {Antioxidants & Redox Signaling},
  year = {2024},
  volume = {40},
  number = {10-12},
  pages = {632--635},
  doi = {10.1089/ars.2023.0398}
}
Kostenlos starten →